156 related articles for article (PubMed ID: 17346675)
1. N-methyltetrahydro-beta-carboline analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin are oxidized to neurotoxic beta-carbolinium cations by heme peroxidases.
Herraiz T; Guillén H; Galisteo J
Biochem Biophys Res Commun; 2007 Apr; 356(1):118-23. PubMed ID: 17346675
[TBL] [Abstract][Full Text] [Related]
2. Metabolite profile resulting from the activation/inactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 2-methyltetrahydro-β-carboline by oxidative enzymes.
Herraiz T; Guillén H; Galisteo J
Biomed Res Int; 2013; 2013():248608. PubMed ID: 23984327
[TBL] [Abstract][Full Text] [Related]
3. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
[TBL] [Abstract][Full Text] [Related]
4. Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes.
Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
Glia; 1992; 5(1):48-55. PubMed ID: 1311704
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt MV; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
[TBL] [Abstract][Full Text] [Related]
6. Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Chiba K; Peterson LA; Castagnoli KP; Trevor AJ; Castagnoli N
Drug Metab Dispos; 1985; 13(3):342-7. PubMed ID: 2861994
[TBL] [Abstract][Full Text] [Related]
7. Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products.
Drucker G; Raikoff K; Neafsey EJ; Collins MA
Brain Res; 1990 Feb; 509(1):125-33. PubMed ID: 2137718
[TBL] [Abstract][Full Text] [Related]
8. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Singer TP; Salach JI; Crabtree D
Biochem Biophys Res Commun; 1985 Mar; 127(2):707-12. PubMed ID: 3872126
[TBL] [Abstract][Full Text] [Related]
9. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases.
Singer TP; Salach JI; Castagnoli N; Trevor A
Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461
[TBL] [Abstract][Full Text] [Related]
10. The neurotoxins 1-methyl-4-phenylpyridinium and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles.
Sokol PP; Holohan PD; Ross CR
J Pharmacol Exp Ther; 1987 Jul; 242(1):152-7. PubMed ID: 2956410
[TBL] [Abstract][Full Text] [Related]
11. Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+).
Neafsey EJ; Drucker G; Raikoff K; Collins MA
Neurosci Lett; 1989 Nov; 105(3):344-9. PubMed ID: 2594220
[TBL] [Abstract][Full Text] [Related]
12. Differential cytotoxicities of N-methyl-beta-carbolinium analogues of MPP+ in PC12 cells: insights into potential neurotoxicants in Parkinson's disease.
Cobuzzi RJ; Neafsey EJ; Collins MA
J Neurochem; 1994 Apr; 62(4):1503-10. PubMed ID: 8133278
[TBL] [Abstract][Full Text] [Related]
13. Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures.
Di Monte DA; Schipper HM; Hetts S; Langston JW
Glia; 1995 Oct; 15(2):203-6. PubMed ID: 8567072
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of monoamine oxidase by 3,3-dimethyl analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl-2,3-dihydropyridinium ion. Dramatic effect of beta-mercaptoethanol on substrate turnover and enzyme inactivation.
Hiebert CK; Sayre LM; Silverman RB
J Biol Chem; 1989 Dec; 264(36):21516-21. PubMed ID: 2600079
[TBL] [Abstract][Full Text] [Related]
15. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Castagnoli N; Chiba K; Trevor AJ
Life Sci; 1985 Jan; 36(3):225-30. PubMed ID: 3871243
[TBL] [Abstract][Full Text] [Related]
16. EPR kinetic studies of superoxide radicals generated during the autoxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium, a bioactivated intermediate of parkinsonian-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Zang LY; Misra HP
J Biol Chem; 1992 Nov; 267(33):23601-8. PubMed ID: 1331093
[TBL] [Abstract][Full Text] [Related]
17. Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes.
Di Monte D; Ekström G; Shinka T; Smith MT; Trevor AJ; Castagnoli N
Chem Biol Interact; 1987; 62(2):105-16. PubMed ID: 3496169
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances.
Sayre LM; Wang FJ; Arora PK; Riachi NJ; Harik SI; Hoppel CL
J Neurochem; 1991 Dec; 57(6):2106-15. PubMed ID: 1940917
[TBL] [Abstract][Full Text] [Related]
19. Interactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium species with synthetic dopamine-melanin.
Wu EY; Chiba K; Trevor AJ; Castagnoli N
Life Sci; 1986 Nov; 39(18):1695-700. PubMed ID: 3490611
[TBL] [Abstract][Full Text] [Related]
20. Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations.
Cashman JR; Ziegler DM
Mol Pharmacol; 1986 Feb; 29(2):163-7. PubMed ID: 3485239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]